• PDF: Delivered by email usually within 12 to 24 UK business hours.

Adherex Technologies - Product Pipeline Review
Q4 2010

Adherex Technologies - Product Pipeline Review Q4 2010

Adherex Technologies - Product Pipeline Review - Q4 2010

Summary

Global Market Direct's pharmaceuticals report, "Adherex Technologies - Product Pipeline Review - Q4 2010" provides data on the company's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company's future therapy areas of focus.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct's team of industry experts.

Scope

  • Adherex Technologies - company overview including business description, key employees, and other facts.
  • Review of current pipeline of Adherex Technologies human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
  • Product profiles for late stage and clinical stage products of Adherex Technologies with complete description of the product's developmental history, mechanism of action, clinical trials, major milestones and others.
  • Recent updates of the Adherex Technologies's pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Adherex Technologies's strategic position with total access to a detailed intelligence on its product pipeline.
  • Assess the growth potential of Adherex Technologies in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Adherex Technologies's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Adherex Technologies.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Adherex Technologies and identify potential opportunities in those areas.
  • Do deals with an understanding of the mergers and partnerships that have shaped the sector.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
  • 3 Adherex Technologies Snapshot
    • 3.1 Business Description
  • 4 Adherex Technologies- Research and Development Overview
    • 4.1 Key Therapeutic Areas
  • 5 Adherex Technologies- Pipeline Review
    • 5.1 Pipeline Products by Stage of Development
    • 5.2 Pipeline Products-Monotherapy
    • 5.3 Pipeline Products-Combination Treatment Modalities
  • 6 Adherex Technologies Pipeline Products Glance
    • 6.1 Adherex Technologies Phase II Pipeline
    • 6.2 Adherex Technologies Phase I Pipeline
    • 6.3 Adherex Technologies Pre-Clinical Pipeline
  • 7 Adherex Technologies - Drug Profiles
    • 7.1 Product 1
    • 7.1.1 Product Description
    • 7.1.2 Mechanism of Action
    • 7.1.3 R&D Progress
  • 8 Adherex Technologies Pipeline Analysis
    • 8.1 Adherex Technologies Pipeline Products by Therapeutic Class
    • 8.2 Adherex Technologies Pipeline Products by Target
    • 8.3 Adherex Technologies Pipeline by Route of Administration
    • 8.4 Adherex Technologies Pipeline Products by Molecule Type
  • 9 Adherex Technologies- Recent Pipeline Updates
  • 10 Adherex Technologies- Dormant Pipeline Projects
    • 10.1 Feature on Dormant Projects
  • 11 Adherex Technologies- Discontinued Pipeline Products
    • 11.1 Discontinued Pipeline Product Profiles
    • 11.1.1 Product 1
  • 12 Adherex Technologies - Featured News
  • 13 Adherex Technologies Statement
    • 13.1 Adherex Technologies - Locations and Subsidiaries
  • 14 Appendix
    • 14.1 Global Markets Direct Research Methodology
    • 14.2 Coverage
    • 14.3 Secondary Research
    • 14.4 Primary Research
    • 14.5 Models
    • 14.6 Expert Panels
    • 14.7 Contact Us
    • 14.8 Disclaimer
  • 1.1 List of Tables
    • Table 1: Adherex Technologies - Key Information
    • Table 2: Adherex Technologies - Key Facts
    • Table 3: Adherex Technologies - Key Therapeutic Areas
    • Table 4: Adherex Technologies - Pipeline by Stage of Development, 2010
    • Table 5: Adherex Technologies - Monotherapy Products in Pipeline, 2010
    • Table 6: Adherex Technologies - Combination Treatment Modalities in Pipeline, 2010
    • Table 7: Adherex Technologies - Phase II Pipeline, 2010
    • Table 8: Adherex Technologies - Phase I Pipeline, 2010
    • Table 9: Adherex Technologies - Pre-Clinical Pipeline, 2010
    • Table 10: Adherex Technologies - Pipeline By Therapeutic Class
    • Table 11: Adherex Technologies - Pipeline By Target
    • Table 12: Adherex Technologies - Pipeline By Route of Administration
    • Table 13: Adherex Technologies - Pipeline By Molecule Type
    • Table 14: Adherex Technologies - Recent Pipeline Updates
    • Table 15: Adherex Technologies - Dormant Pipeline Projects
  • 1.2 List of Figures
    • Figure 1: Adherex Technologies - Research and Development Overview
    • Figure 2: Adherex Technologies - Pipeline by Stage of Development, 2010
    • Figure 3: Adherex Technologies - Monotherapy Products in Pipeline, 2010
    • Figure 4: Adherex Technologies - Combination Treatment Modalities in Pipeline, 2010
    • Figure 5: Adherex Technologies - Pipeline By Therapeutic Class and Stage of Development
    • Figure 6: Adherex Technologies - Pipeline By Therapeutic Class
    • Figure 7: Adherex Technologies - Pipeline By Target and Stage of Development
    • Figure 8: Adherex Technologies - Pipeline By Target
    • Figure 9: Adherex Technologies - Pipeline By Route of Administration and Stage of Development
    • Figure 10: Adherex Technologies - Pipeline By Route of Administration
    • Figure 11: Adherex Technologies - Pipeline By Molecule Type and Stage of Development
    • Figure 12: Adherex Technologies - Pipeline By Molecule Type
+44 20 8816 8548

Ask a question about Adherex Technologies - Product Pipeline Review

Enter the characters you see in the picture below
Captcha